FDA approves first treatment for pediatric patients with lupus

FDA approves Benlysta for treatment of children with systemic lupus erythematosus (SLE), a chronic disease causing inflammation and damage to tissue and organs
Source: Food and Drug Administration - Category: American Health Authors: Source Type: news